$BLGO
BIOLARGO, INC. Stock $blgo

$blgo Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924016682 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$5.014M	$4.760M
YoY Change	246.75%	27.2%
Cost Of Revenue	$2.877M	$2.514M
YoY Change	358.85%	30.12%
Gross Profit	$2.137M	$2.246M
YoY Change	160.93%	24.09%
Gross Profit Margin	42.62%	47.18%
Selling, General & Admin	$2.404M	$2.225M
YoY Change	34.23%	29.21%
% of Gross Profit	112.49%	99.07%
Research & Development	$623.0K	$784.0K
YoY Change	6.13%	38.76%
% of Gross Profit	29.15%	34.91%
Depreciation & Amortization	$38.00K	$36.00K
YoY Change	46.15%	63.64%
% of Gross Profit	1.78%	1.6%
Operating Expenses	$3.027M	$3.009M
YoY Change	27.29%	31.57%
Operating Profit	-$890.0K	-$763.0K
YoY Change	-42.91%	59.96%
Interest Expense	$2.000K	$12.00K
YoY Change	-83.33%	-75.0%
% of Operating Profit
Other Income/Expense, Net	$110.0K	-$12.00K
YoY Change	-264.18%	-29.41%
Pretax Income	-$780.0K	-$775.0K
YoY Change	-52.03%	56.88%
Income Tax
% Of Pretax Income
Net Earnings	-$780.0K	-$775.0K
YoY Change	-52.03%	56.88%
Net Earnings / Revenue	-15.56%	-16.28%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	296.8M	295.6M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.765M	$4.336M
YoY Change	33.29%	32.84%
Cash & Equivalents	$4.765M	$4.336M
Short-Term Investments
Other Short-Term Assets	$65.00K	$116.0K
YoY Change	-39.81%	22.11%
Inventory	$176.0K	$251.0K
Prepaid Expenses
Receivables	$2.104M	$2.473M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$7.110M	$7.176M
YoY Change	46.69%	47.23%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.811M	$1.489M
YoY Change	234.13%	280.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$18.00K	$18.00K
YoY Change	-14.29%	-33.33%
Other Assets	$70.00K	$70.00K
YoY Change	1.45%	-43.55%
Total Long-Term Assets	$2.943M	$2.645M
YoY Change	60.56%	49.18%
TOTAL ASSETS
Total Short-Term Assets	$7.110M	$7.176M
Total Long-Term Assets	$2.943M	$2.645M
Total Assets	$10.05M	$9.821M
YoY Change	50.49%	47.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.473M	$1.663M
YoY Change	205.6%	60.06%
Accrued Expenses	$164.0K	$209.0K
YoY Change	46.43%	-29.39%
Deferred Revenue	$85.00K	$261.0K
YoY Change	750.0%	1142.86%
Short-Term Debt	$234.0K	$234.0K
YoY Change
Long-Term Debt Due	$66.00K	$66.00K
YoY Change	0.0%	0.0%
Total Short-Term Liabilities	$3.012M	$3.404M
YoY Change	132.77%	89.22%
LONG-TERM LIABILITIES
Long-Term Debt	$184.0K	$284.0K
YoY Change	-38.46%	-5.96%
Other Long-Term Liabilities	$965.0K	$985.0K
YoY Change	33.84%	31.86%
Total Long-Term Liabilities	$1.149M	$1.269M
YoY Change	-9.03%	-2.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.012M	$3.404M
Total Long-Term Liabilities	$1.149M	$1.269M
Total Liabilities	$4.161M	$4.673M
YoY Change	62.73%	50.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$147.9M	-$147.5M
YoY Change	1.92%	2.55%
Common Stock	$200.0K	$198.0K
YoY Change	4.17%	4.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.002M	$8.115M
YoY Change
Total Liabilities & Shareholders Equity	$10.05M	$9.821M
YoY Change	50.49%	47.75%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$780.0K	-$775.0K
YoY Change	-52.03%	56.88%
Depreciation, Depletion And Amortization	$38.00K	$36.00K
YoY Change	46.15%	63.64%
Cash From Operating Activities	-$151.0K	$481.0K
YoY Change	-89.82%	-1218.6%
INVESTING ACTIVITIES
Capital Expenditures	$358.0K	$863.0K
YoY Change	353.16%	1697.92%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$358.0K	-$863.0K
YoY Change	353.16%	1697.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	999.0K	$1.083M
YoY Change	-46.89%	-28.28%
NET CHANGE
Cash From Operating Activities	-151.0K	$481.0K
Cash From Investing Activities	-358.0K	-$863.0K
Cash From Financing Activities	999.0K	$1.083M
Net Change In Cash	490.0K	$797.0K
YoY Change	54.09%	-43.6%
FREE CASH FLOW
Cash From Operating Activities	-$151.0K	$481.0K
Capital Expenditures	$358.0K	$863.0K
Free Cash Flow	-$509.0K	-$382.0K
YoY Change	-67.43%	319.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00067
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00067
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00067
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00067
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	295801370
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	292945747
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	39000	usd
CY2024Q1	blgo	Number Of Wholly Owned Subsidiaries NumberOfWhollyOwnedSubsidiaries	5	pure
CY2024Q1	blgo	Number Of Partiallyowned Subsidiaries NumberOfPartiallyownedSubsidiaries	3	pure
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	84000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	212000	usd
CY2021Q4	blgo	Number Of Patents Acquired NumberOfPatentsAcquired	3	pure
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2024Q1	blgo	Stock Option Plan Expense Period Of Recognition StockOptionPlanExpensePeriodOfRecognition	P4Y
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	134000	usd
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	6	pure
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	88000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P4Y
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Trd Arr Securities Agg Avail Amt TrdArrSecuritiesAggAvailAmt	766175
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	000-19709
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	65-0159115
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	14921 Chestnut St.
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Westminster
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92683
CY2024Q1	dei	City Area Code CityAreaCode	888
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	400-2863
CY2024Q1	dei	Security12b Title Security12bTitle	Common stock
CY2024Q1	dei	Trading Symbol TradingSymbol	BLGO
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	296839523
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4336000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3539000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2473000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2612000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	251000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	153000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	116000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	58000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	7176000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	6362000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1489000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	662000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	70000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	70000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	18000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	19000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1068000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1092000	usd
CY2024Q1	us-gaap	Assets Assets	9821000	usd
CY2023Q4	us-gaap	Assets Assets	8205000	usd
CY2024Q1	blgo	Debt Obligation Current DebtObligationCurrent	66000	usd
CY2023Q4	blgo	Debt Obligation Current DebtObligationCurrent	66000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	261000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	303000	usd
CY2024Q1	blgo	Customer Deposit Liability Current CustomerDepositLiabilityCurrent	226000	usd
CY2023Q4	blgo	Customer Deposit Liability Current CustomerDepositLiabilityCurrent	117000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3404000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2710000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	284000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	289000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	985000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1004000	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1269000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1293000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	4673000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4003000	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	198000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	196000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	155606000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	154023000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-147508000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-147098000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-181000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-277000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	8115000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6844000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-2967000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-2642000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5148000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4202000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9821000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8205000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4760000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3742000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2514000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1932000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	2246000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1810000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2225000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1722000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	784000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	565000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	3009000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2287000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-763000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-477000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	12000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	48000	usd
CY2024Q1	blgo	Nonoperating Income Grant Income NonoperatingIncomeGrantIncome	0	usd
CY2023Q1	blgo	Nonoperating Income Grant Income NonoperatingIncomeGrantIncome	31000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-12000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-17000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-775000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-494000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-365000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-247000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-410000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-247000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.001
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.001
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	294308798
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	280711278
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-775000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-494000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	96000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-6000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-679000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-500000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-365000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-247000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-314000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-253000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4202000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	488000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	83000	usd
CY2024Q1	blgo	Adjustments To Additional Paidin Capital Warrant Exercised AdjustmentsToAdditionalPaidinCapitalWarrantExercised	75000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	429000	usd
CY2024Q1	blgo	Adjustments To Additional Paid In Capital Increase From Subsidiary Equity Issued For Service AdjustmentsToAdditionalPaidInCapitalIncreaseFromSubsidiaryEquityIssuedForService	59000	usd
CY2024Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	52000	usd
CY2024Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	86000	usd
CY2024Q1	blgo	Stockholders Equity Allocation Of Noncontrolling Interest From Subsidiarys Equity Issuance StockholdersEquityAllocationOfNoncontrollingInterestFromSubsidiarysEquityIssuance	0	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-775000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	96000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5148000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2011000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	800000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	207000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	195000	usd
CY2023Q1	blgo	Adjustments To Additional Paid In Capital Increase From Subsidiary Equity Issued For Service AdjustmentsToAdditionalPaidInCapitalIncreaseFromSubsidiaryEquityIssuedForService	61000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	30000	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	225000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	27000	usd
CY2023Q1	blgo	Stockholders Equity Allocation Of Noncontrolling Interest From Subsidiarys Equity Issuance StockholdersEquityAllocationOfNoncontrollingInterestFromSubsidiarysEquityIssuance	0	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-494000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-6000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3552000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-775000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-494000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	488000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	256000	usd
CY2024Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	135000	usd
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	207000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	24000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3000	usd
CY2024Q1	blgo	Fair Value Of Warrant Issued For Interest FairValueOfWarrantIssuedForInterest	0	usd
CY2023Q1	blgo	Fair Value Of Warrant Issued For Interest FairValueOfWarrantIssuedForInterest	30000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	36000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	22000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-139000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	316000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	98000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	17000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	58000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-25000	usd
CY2024Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-109000	usd
CY2023Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	71000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-42000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	4000	usd
CY2024Q1	blgo	Increase Decrease In Right Of Use And Lease Liability Net IncreaseDecreaseInRightOfUseAndLeaseLiabilityNet	-19000	usd
CY2023Q1	blgo	Increase Decrease In Right Of Use And Lease Liability Net IncreaseDecreaseInRightOfUseAndLeaseLiabilityNet	4000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	481000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-43000	usd
CY2024Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	863000	usd
CY2023Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	48000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-863000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-48000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	488000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	800000	usd
CY2024Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	75000	usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2024Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	5000	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	50000	usd
CY2024Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-0	usd
CY2023Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	15000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	225000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1083000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1510000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	96000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-6000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	797000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1413000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3539000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1851000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4336000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3264000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	12000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	15000	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	5000	usd
CY2024Q1	blgo	Shortterm Lease Payments Not Included In Lease Liability ShorttermLeasePaymentsNotIncludedInLeaseLiability	12000	usd
CY2023Q1	blgo	Shortterm Lease Payments Not Included In Lease Liability ShorttermLeasePaymentsNotIncludedInLeaseLiability	13000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	80000	usd
CY2024Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	399000	usd
CY2023Q1	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	467000	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	86000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4760000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-775000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	481000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	7176000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4336000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3404000	usd
CY2024Q1	blgo	Working Capital Deficit WorkingCapitalDeficit	3772000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	481000	usd
CY2024Q1	blgo	Conversion Of Assets Contingency Accounts Receivable To Cash ConversionOfAssetsContingencyAccountsReceivableToCash	2473000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4336000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3539000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	84000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	212000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	85000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	79000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	166000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	74000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	251000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	153000	usd
CY2024Q1	blgo	Patents Noncurrent PatentsNoncurrent	34000	usd
CY2023Q4	blgo	Patents Noncurrent PatentsNoncurrent	34000	usd
CY2024Q1	blgo	Security Deposits Noncurrent SecurityDepositsNoncurrent	36000	usd
CY2023Q4	blgo	Security Deposits Noncurrent SecurityDepositsNoncurrent	36000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	70000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	70000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	261000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	303000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	42000	usd
CY2024Q1	blgo	Revenue Recognized From Customer Deposits RevenueRecognizedFromCustomerDeposits	4000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.18	pure
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1068000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1092000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1090000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1109000	usd
CY2024Q1	us-gaap	Debt Current DebtCurrent	66000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	66000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	284000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	289000	usd
CY2024Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	350000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	355000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	12000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	48000	usd
CY2024Q1	us-gaap	Share Price SharePrice	0.35
CY2024Q1	us-gaap	Share Price SharePrice	0.35
CY2024Q1	us-gaap	Share Price SharePrice	0.35
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	83000	usd
CY2023	blgo	Increase Decrease In Operating Lease Rightofuse Assets IncreaseDecreaseInOperatingLeaseRightofuseAssets	394000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.18	pure
CY2024Q1	blgo	Remaining Stock Option Plan Expense RemainingStockOptionPlanExpense	1056000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	49023398
CY2023Q1	blgo	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	7512000
CY2023Q1	blgo	Class Of Warrant Or Right Expired During Period ClassOfWarrantOrRightExpiredDuringPeriod	4684986
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	51850412
CY2023Q1	blgo	Warrants Outstanding Weighted Average Remaining Term WarrantsOutstandingWeightedAverageRemainingTerm	P2Y4M24D
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	122000	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	51590300
CY2024Q1	blgo	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	3218422
CY2024Q1	blgo	Class Of Warrant Or Right Expired During Period ClassOfWarrantOrRightExpiredDuringPeriod	406278
CY2024Q1	blgo	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	600000
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	53802444
CY2024Q1	blgo	Warrants Outstanding Weighted Average Remaining Term WarrantsOutstandingWeightedAverageRemainingTerm	P2Y
CY2024Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	4021000	usd
CY2024Q1	us-gaap	Share Price SharePrice	0.35
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1663000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	77000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1740000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1212000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	251000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	25000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1488000	usd
CY2024Q1	us-gaap	Line Of Credit LineOfCredit	134000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4760000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3742000	usd
CY2024Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	488000	usd
CY2023Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	256000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	36000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	22000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	784000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	565000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-763000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-477000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-12000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-48000	usd
CY2024Q1	blgo	Finitelived Tangible Assets Net FinitelivedTangibleAssetsNet	8735000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1068000	usd
CY2024Q1	blgo	Tangible And Intangible Assets Rightofuse Assets And Equity Method Investment Total TangibleAndIntangibleAssetsRightofuseAssetsAndEquityMethodInvestmentTotal	9821000	usd
CY2023Q4	blgo	Finitelived Tangible Assets Net FinitelivedTangibleAssetsNet	7094000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1092000	usd
CY2023Q4	blgo	Tangible And Intangible Assets Rightofuse Assets And Equity Method Investment Total TangibleAndIntangibleAssetsRightofuseAssetsAndEquityMethodInvestmentTotal	8205000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2042000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	276000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	282000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	289000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	296000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	245000	usd
CY2023Q4	blgo	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	654000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2042000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	933000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1109000	usd

Files In Submission

Name	View Source	Status
0001437749-24-016682-index-headers.html	Edgar Link	pending
0001437749-24-016682-index.html	Edgar Link	pending
0001437749-24-016682.txt	Edgar Link	pending
0001437749-24-016682-xbrl.zip	Edgar Link	pending
blgo-20240331.xsd	Edgar Link	pending
blgo20240331_10q.htm	Edgar Link	pending
ex_645223.htm	Edgar Link	pending
ex_645224.htm	Edgar Link	pending
ex_645225.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
blgo-20240331_cal.xml	Edgar Link	unprocessable
blgo-20240331_def.xml	Edgar Link	unprocessable
blgo-20240331_lab.xml	Edgar Link	unprocessable
blgo-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
blgo20240331_10q_htm.xml	Edgar Link	completed
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BLGO
BIOLARGO, INC. Stock $blgo

2024 Q2 Form 10-Q Financial Statement

#000143774924016682 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLGO BIOLARGO, INC. Stock $blgo

2024 Q2 Form 10-Q Financial Statement

#000143774924016682 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLGO
BIOLARGO, INC. Stock $blgo